89bio to present at the oppenheimer 31st annual healthcare conference

San francisco, march 11, 2021 (globe newswire) -- 89bio, inc. (nasdaq: etnb), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that company's management will present at the oppenheimer 31st annual healthcare conference, a virtual event, on wednesday, march 17, 2021 at 1:10 p.m. et.
ETNB Ratings Summary
ETNB Quant Ranking